Shares Of Dr Reddy's Laboratories Slipped 4 Percent In Early Trade On Monday

Shares of Dr Reddy's Laboratories slipped 4 percent in early trade on Monday after the USFDA maintained OAI status for the company's Srikakulam plant.

The company received the establishment inspection report from the US Food and Drug Administration for its API manufacturing plant in Srikakulam, Andhra Pradesh.

"FDA has asked us for more details. We are providing those details and continuing to engage with FDA for resolution of pending issues," company said in press release.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory